Mylan Laboratories News

The Mylan Puskar Health Right Marion County Outreach held a ribbon cutting Tuesday, and city, county and state officials gathered at the Soup Opera on Quincy Street in the afternoon to celebrate its preparedness to serve the uninsured.

Mylan Pharmaceuticals is suing the Pittsburgh Post-Gazette again, this time for libel.

Sometimes, using equity to grow can come back to bite you . Teva Pharmaceuticals ' acquisition of Barr Pharmaceuticals helped boost its net income in the third quarter, but its earnings per share fell as that larger pie was split into a greater number of pieces.

This isn't an anti-obesity message. It's a pitch for drugs. Specifically the EpiPen auto-injector that counters severe allergic reactions, and is distributed by Mylan 's Dey Pharma unit.

Filed under: Earnings reports , Allergan One would expect generic U.S. drugmaker Mylan to benefit from all this talk about increased generic competitions, but revenue only increased 5.2 percent to $1.26 billion on an operational basis, beating analyst revenue estimates of $1.23 billion.

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.

Two years after Mylan Inc. completed a $6.8 billion deal for Merck KGaA's worldwide generic drug business, CEO Robert J. Coury is looking for deals to acquire makers of brand-name drugs.

Generic drug-maker Mylan Inc. sunk into the red in the third quarter after taking a charge to settle claims by the U.S. Justice Department that it inflated prices of drugs sold to Medicaid patients.

Dey Pharma, L.P., a subsidiary of Mylan Inc. , launched a newly designed, patient-friendly EpiPen Auto-Injector 0.3/0.15 mg.

Mylan Laboratories on Thursday reported a third-quarter net loss of $40 million, or 13 cents a share, compared to profit of $182.4 million, or 47 cents a share, in the same period a year ago.

It's not exactly Pfizer taking out Wyeth, or Mylan swallowing Merck KGaA's generic business, but Rule Breakers pick BioMarin Pharmaceuticals still made a solid pickup on Monday.

Dey Pharma, L.P., a subsidiary of Mylan Inc. , today launched a newly designed, patient-friendly EpiPenA Auto-Injector 0.3/0.15 mg.

Drug maker Mylan Inc. said today that two of its subsidiaries have reached a $121 million settlement in a dispute with the Department of Justice over Medicaid rebates.

Diversified healthcare giant Johnson & Johnson reported third quarter results on Tuesday that beat analyst profit targets.

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has received approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Topiramate Capsules , 15 mg and 25 mg.

Founded in Jerusalem in 1901, Teva is the only drugmaker that is a leader in both generics and branded pharmaceuticals.

BUYINS.NET, www.buyins.net, has reviewed the NYSE Daily Short Volume Report for Wednesday, October 6th, 2009 and come to the following statistical conclusions.

Starting this weekend, Decision Makers will become one hour in length and will air Sunday at 8 a.m. On this weekend's Decision Makers, host Bray Cary sits down with Mylan President Heather Bresch to discuss her role as president of one of the worlda s leading generics and specialty pharmaceutical companies and how her West Virginia upbringing ...

Shares of generic drugmaker Mylan dropped for the third straight session Thursday but drew heavy upside options activity.

In a development that would enable better and more affordable treatment for HIV/AIDS patients on second-line antiretroviral therapy in the developing world, the Clinton HIV/AIDS Initiative , Mylan Inc and Hyderabad-based Matrix Laboratories have signed an agreement to offer a once-daily dose of the second-line regimen of four ARVs for under $500 ...